0 Views
administrator
administrator
07/13/23

Over a decade ago, Dr Thomas Seyfried, a trailblazer in the arena of conquering cancer, published his groundbreaking book Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer, which provided extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This theory has incredible implications for the development of new non-toxic cancer therapies. In an interview with Dr Seyfried, he explained the virtues of this concept, the dogmatic ideology that is suppressing its development in mainstream medicine, and how the current cancer treatment is killing patients. A stunning interview with thought-provoking revelations.

TIMESTAMPS.

00:00 Dr Thomas Seyfried on the report released on 25 May of a study by a team of international researchers, of which he was a co-author, which found a non-toxic combination that destroys the two major cells in glioblastoma
09:01 On the metabolic therapies that are able to treat cancer
11:50 On the prevailing genetic theory of cancer as a disease and the contrasting mitochondrial metabolic definition of cancer
14:19 On mitochondria
18:11 On the misconception that every cancer is different and the prevalence of several modern illnesses being regarded as metabolic diseases
22:42 On the systemic problem of doctors not being allowed to recommend alternative treatments for cancer
24:43 On Otto Warburg's theory on the origin of cancer
26:28 On ideological dogma in the medical profession
29:58 On the challenges facing the metabolic therapy cancer treatment trials going ahead
33:36 On the funding of these trials
36:14 On his recommended preventative measures in respect of developing cancer
38:28 On whether there are any factors, apart from carcinogens and inflammation, etc., that can induce cancer
44:47 On the metabolic therapy cancer treatment trial
47:06 On whether metabolic therapies should be used alongside chemotherapy

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next